FDA Seeks Comment on Lasik Postmarket Experience

To better understand quality-of-life issues following Lasik eye surgery, the FDA is asking the public to comment on the procedure. The comment period follows an April 25 advisory panel meeting that was held to gather suggestions on tools the agency could use to improve patient safety with Lasik. The committee recommended several measures to strengthen the warnings that accompany excimer lasers, such as clarifying the conditions that make patients undesirable candidates and adding statistics on the frequency of various side effects. Comments are due by Sept. 14, 2009.